Research & Development

The Eurofins Diatherix Research and Development team strives to be a dynamic and nimble group developing solutions to improve patient outcomes through application of Eurofins Diatherix TEM-PCR and related technologies. The R&D group consists of scientists with diverse educational experience in microbiology, chemistry, molecular biology, and engineering. Leveraging unique perspectives, the group develops innovative applications to change the way physicians treat patients.

Eurofins Diatherix R&D drives the development of new tests by listening to feedback from physicians, identifying unmet needs, and delivering medical care providers with solutions to better serve their patients. All tests are monitored on a recurrent basis to ensure content is current and inclusive of new and emerging strains.